Hosking wins Bay Crits day two
Sprinter takes over general classification
Chloe Hosking, riding for the Lexus of Blackburn team at this year's Bay Crits, took victory on day two of the series on a Ritchie Boulevard course in Geelong, Australia, by out-sprinting breakaway companions Valentina Scandolara (Roxsolt Attaquer) and Matilda Raynolds.
Scandolara and Hosking got away together just before the half-hour mark of the 45-minute race, and it was immediately clear that it was a serious, and dangerous, move.
While former Bay Crits champion Hosking would have had winning on her mind, she at first appeared reticent to ride with defending champion Scandolara – especially as Hosking's Lexus teammate and overall race leader Amanda Spratt, who won Tuesday's opening race, was behind them in a depleted peloton.
After a couple more laps at the head of the race around the 650-metre circuit, the duo were joined by Australian Matilda Raynolds, and it became clear that the move was going to stick and all three riders committed to the cause.
In the sprint for the line, Hosking was able to hold off Scandolara, with Raynolds out of the mix, but holding on for a well-deserved podium spot.
"I spoke a lot to my coach this season about trying to pick up results in smaller races to give me the confidence for the bigger races, so I can use this for that," Hosking said at the finish. "But I still know there's a lot of work to go, and I'm fortunate in that this course is really suited to my strengths, so it's easy to hide my weaknesses."
Rebecca Wiasak won the sprint for fourth place, almost 20 seconds down, which puts her equal on points with Hosking and Scandolara heading into the final race in Williamstown on Thursday, with Spratt having dropped to fourth, a point behind, after taking seventh place.
Results
# | Rider Name (Country) Team | Result |
---|---|---|
1 | Chloe Hosking (Aus) Lexus Of Blackburn | 00:44:05 |
2 | Valentina Scandolara (Ita) Roxsolt Attaquer | Row 1 - Cell 2 |
3 | Matilda Raynolds (Aus) | 0:00:02 |
4 | Rebecca Wiasak (Aus) | 0:00:17 |
5 | Peta Mullens (Aus) Roxsolt Attaquer | Row 4 - Cell 2 |
6 | Emma Chilton (Aus) Roxsolt Attaquer | Row 5 - Cell 2 |
7 | Amanda Spratt (Aus) Lexus Of Blackburn | Row 6 - Cell 2 |
8 | Natalie Redmond (Aus) | Row 7 - Cell 2 |
9 | Renata Bucher (Swi) Roxsolt Attaquer | Row 8 - Cell 2 |
10 | Veronica Lebedev (Aus) Gusto Stepfwd Kom Powered By Suzuki | Row 9 - Cell 2 |
# | Rider Name (Country) Team | Result | Header Cell - Column 3 |
---|---|---|---|
1 | Chloe Hosking (Aus) Lexus Of Blackburn | 17 | pts |
2 | Valentina Scandolara (Ita) Roxsolt Attaquer | 17 | Row 1 - Cell 3 |
3 | Rebecca Wiasak (Aus) | 17 | Row 2 - Cell 3 |
4 | Amanda Spratt (Aus) Lexus Of Blackburn | 16 | Row 3 - Cell 3 |
5 | Matilda Raynolds (Aus) | 8 | Row 4 - Cell 3 |
6 | Shannon Mccurley (Aus) | 8 | Row 5 - Cell 3 |
7 | Peta Mullens (Aus) Roxsolt Attaquer | 6 | Row 6 - Cell 3 |
8 | Emma Chilton (Aus) Roxsolt Attaquer | 6 | Row 7 - Cell 3 |
9 | Ruby Roseman-Gannon (Aus) | 6 | Row 8 - Cell 3 |
10 | Nicola Macdonald (Aus) Gusto StepFWD KOM Powered By Suzuki | 4 | Row 9 - Cell 3 |
Get The Leadout Newsletter
The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!
Most Popular
Latest on Cyclingnews
-
Astana Development Team rider handed four-year ban for CERA positives
Kazakhstani youngster Ilhan Dostiyev was caught by two tests as he finished second at Giro della Valle d'Aosta and won the Turul Romaniei -
A modest star: Grand Tour climbing genius Sepp Kuss on why staying under the radar works best for him
2023 Vuelta a España winner discusses quest for consistency after uneven 2024, Tour de France, and hiding GC ambitions in plain sight -
Olympic medals, rainbow jerseys and a 104-tooth chainring: Inside the engineering legend of Royce
British brand Royce has been responsible for some of the finest hubs, bottom brackets and components of the last 40 years -
'Having to learn everything in life at 21' - Joey Pidcock reveals ADHD diagnosis and how medication was life-changing
Young Briton admits medication and therapy treatments provided marked improvements from 'sinister' health issues